Healthy Volunteers Clinical Trial
Official title:
Acute Effects of Energy Drink on Hemodynamic and Electrophysiologic Parameters in Habitual and Non-Habitual Caffeine Consumers
| NCT number | NCT04223167 |
| Other study ID # | 2017/1211 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 20, 2018 |
| Est. completion date | May 14, 2019 |
| Verified date | January 2020 |
| Source | Aydin Adnan Menderes University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The consumption of energy drinks has significantly increased in recent years but their
adverse effects are not yet efficiently known. The objective of the study is to determine the
acute effects of energy drink on habitual and non-habitual caffeine consumers and if caffeine
consumption habit causes a difference on the hemodynamic and electrophysiologic parameters.
This study was conducted on 48 students selected from Aydın Adnan Menderes University. Four
main groups were determined according to the results of the application acceptance survey.
Blood pressure, electrocardiogram, breath rate, haemoglobin oxygen saturation and
bioelectrical impedance analysis were measured before consuming the drinks. After consuming
the drinks, measurements were repeated at 30 minutes and 60 minutes. In addition to this,
Participant's Situation Anxiety Scale was applied.
| Status | Completed |
| Enrollment | 48 |
| Est. completion date | May 14, 2019 |
| Est. primary completion date | May 14, 2019 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 24 Years |
| Eligibility |
Inclusion Criteria: - Healthy volunteers between ages 18-24 years Exclusion Criteria: - body mass index greater than 30 kg/m2 - a systemic disease - current alcoholism - smokers - the participants who has previous adverse reactions to energy drinks |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Aydin Adnan Menderes University | Aydin |
| Lead Sponsor | Collaborator |
|---|---|
| Aydin Adnan Menderes University |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in blood pressure from baseline | At baseline and 60 minutes post energy drink and placebo consumption | ||
| Primary | Change in heart rate from baseline | At baseline and 60 minutes post energy drink and placebo consumption | ||
| Secondary | Change in QTc interval from baseline | At baseline and 60 minutes post energy drink and placebo consumption |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |